Immunosuppressive Therapy

Immunosuppressive Therapy is a pharmacologic treatment strategy that uses agents to attenuate or modulate components of the immune response in a controlled manner to prevent or treat allograft rejection and other immune-mediated injury while balancing risks of infection, malignancy, and drug-related toxicity.

8K

Publications

443.1K

Citations

39.4K

Authors

5K

Institutions

Publications per year

2017–2026

1.2K

Authors

39.4K

  1. JJ
    John J. Fung

    University of Pittsburgh, United States

    50 publications · 5K citations

    34

    h-index

  2. TE
    Thomas E. Starzl

    University of Pittsburgh, United States

    43 publications · 4.9K citations

    32

    h-index

  3. RS
    Rainer Storb

    Fred Hutch Cancer Center, United States

    49 publications · 4.5K citations

    31

    h-index

  4. DJ
    David Jayne

    University of Cambridge, United Kingdom

    28 publications · 7.5K citations

    26

    h-index

  5. BD
    Barry D. Kahan

    The University of Texas at Austin, United States

    33 publications · 3.1K citations

    25

    h-index

1–5 of 39.4K

Venues

  1. Transplantation

    943 publications · 57.4K citations

    116

    h-index

  2. PubMed

    Repository · 1K publications · 36.3K citations

    84

    h-index

  3. Blood

    167 publications · 17.4K citations

    80

    h-index

  4. American Journal of Transplantation

    198 publications · 16.9K citations

    69

    h-index

  5. The Journal of Immunology

    JI · 114 publications · 10.3K citations

    55

    h-index

1–5